Stay updated on DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial

Sign up to get notified when there's something new on the DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The site release note now shows Revision: v3.5.4, replacing the previous Revision: v3.5.3. This indicates a new, minor update to the site’s release/version information.
    Difference
    0.0%
    Check dated 2026-05-18T03:53:29.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page’s revision/version marker was updated from v3.5.2 to v3.5.3, reflecting a software release on the site.
    Difference
    0.0%
    Check dated 2026-04-26T15:23:12.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-19T13:43:24.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Revision: v3.5.0 has been added. Revision: v3.4.3 has been removed.
    Difference
    0.0%
    Check dated 2026-03-21T19:55:42.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-07T08:00:42.000Z thumbnail image
  8. Check
    96 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added, replacing v3.4.1; no core study content or user-facing details were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T16:24:19.000Z thumbnail image

Stay in the know with updates to DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial page.